
Research use only. Inquiry required to complete order.
Secure inquiry. Worldwide shipping. Research use only.
View Testing DocumentationReview available testing documentation and current batch information on the COA page.
A pre-mixed blend combining CJC-1295 (a GHRH analog) and Ipamorelin (a selective growth-hormone secretagogue), centered on growth-hormone signaling pathways.
| Type | Pre-mixed blend vial |
| Components | CJC-1295 + Ipamorelin |
| Strength | 5mg + 5mg |
| Appearance | White lyophilized powder |
| Purity | 98%+ (HPLC) each component |
CJC-1295 is a growth-hormone-releasing hormone (GHRH) analog and Ipamorelin is a selective growth-hormone secretagogue. Together they are commonly discussed in connection with growth-hormone release and endocrine signaling pathways.
Testing documentation and current batch information can be reviewed on our COA page.
View Testing DocumentationStore at -20C, protected from light and moisture. Keep sealed until ready for controlled handling. After preparation, store refrigerated at 2C to 8C and follow appropriate handling timelines.
Reconstitute with Bacteriostatic Water. Pairs with our Bacteriostatic Water (BAC Water) 10mL.
Handling and storage information is provided on this page.
CJC-1295 + Ipamorelin is a peptide blend centered on growth-hormone signaling pathways. CJC-1295 is associated with GHRH-pathway activity, while Ipamorelin is commonly discussed in relation to ghrelin-receptor and secretagogue activity.
This blend is commonly studied in growth-hormone pathway models, secretagogue signaling, GHRH-related pathways, and endocrine-axis science.
Studies typically examine how GHRH analogs and ghrelin-receptor secretagogues relate to growth-hormone signaling and peptide-regulated endocrine pathways.
Store at -20C, protected from light and moisture. Keep sealed until ready for controlled handling.
A Certificate of Analysis, or COA, summarizes quality-control details for a material. It may include identity, purity, appearance, molecular weight, batch or lot information, and testing method details when available.


